Product logins

Find logins to all Clarivate products below.


Asthma treatment generally includes rescue therapy to relieve acute exacerbations and maintenance therapy to prevent future attacks. A wide array of well-established therapies spanning multiple classes are available to treat the symptoms of asthma in a step-up manner. With the launch of newer agents with novel mechanisms of action and with more-intense competition from branded-generic/generic alternatives of mainstay inhaler therapies, the treatment landscape is become increasingly complex. As such, understanding the many decision points that clinicians face, as well as the forces that influence their choice of treatment, is crucial for companies facing this complicated market.

The Asthma Current Treatment Overview provides a synopsis of current treatment goals, key therapies, and medical practice in the G7 markets. The detailed, expanded analysis in the Asthma Current Treatment (EU5) offers a snapshot of how pulmonologists in France, Germany, Italy, Spain, and the United Kingdom are managing their asthma patients, as well as insight into the factors driving their prescribing habits.

Related Market Assessment Reports

Report
Asthma – Access & Reimbursement – Access & Reimbursement – Asthma (US)
The dynamics within the LABA/ICS FDC, LAMA, LABA/LAMA/ICS FDC, and biological drug classes will continue to shape the U.S. asthma market. The dominance of branded LABA/ICS FDCs (e.g., GSK’s…
Report
Heart Failure – Current Treatment – Treatment Algorithms: Claims Data Analysis – Heart Failure with Reduced Ejection Fraction (US)
Heart failure with reduced ejection fraction (HFrEF) occurs when the left ventricular ejection fraction (LVEF) is 40% or less. Drug treatment for HFrEF is well established and supported by…
Report
Heart Failure – Current Treatment – Treatment Algorithms: Claims Data Analysis – Heart Failure with Preserved Ejection Fraction (US)
Heart failure with preserved ejection fraction (HFpEF) occurs when the left ventricular ejection fraction (LVEF) is 50% or more. Even though physicians’ understanding of the disease’s…
Report
Irritable Bowel Syndrome – Current Treatment – Treatment Algorithms – Claims Data Analysis – IBS-Diarrhea (US)
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and urgency. The disorder is grouped into three…
Report
Heart Failure – Current Treatment – Treatment Algorithms: Claims Data Analysis – Chronic Heart Failure (US)
Chronic heart failure (CHF) manifests as impaired cardiac function and consequent failure to maintain sufficient blood flow throughout the body to meet its metabolic demands. The CHF therapy market…